Ambys Medicines . Full-time logo

Ambys Medicines . Full-time Employee Directory

Biotechnology ResearchCalifornia, United States2-10 Employees

Ambys Medicines is a biotechnology research company based in South San Francisco, California, focused on hepatocyte transplantation as a therapeutic approach for severe liver disease. It is developing a proprietary cell therapy platform, with its lead program AMI-918 and future engineered hepatocyte therapies intended to address a range of severe liver diseases, including those of acquired and genetic origins. The company has a small team, reported as 2-10 employees, and maintains information on its website. Ambys has expanded its leadership through multiple appointments in 2021–2022, including a Chief Strategy Officer, Chief Human Resources Officer, Vice President of Finance, and Vice President of Regulatory Affairs; it has also formed collaborations such as a partnership with the International Institute for the Advancement of Medicine in 2021. In 2018, Takeda Pharmaceuticals participated in a funding round supporting Ambys' development in cell therapies for liver disease.

Find Ambys Medicines . Full-time employees' phone numbers or email addresses

Ambys Medicines . Full-time Global Highlights

Location
Employees

North America
19

Minus sign iconPlus sign icon
  • United States Of America
    19

Asia
1

Minus sign iconPlus sign icon
  • India
    1

Ambys Medicines . Full-time's Leadership

  • Stylized image of a person
    D. N.
    Talent Discovery Partner, R&d
    Phone icon
  • Stylized image of a person
    S. H.
    Vice President, Research And Nonclinical Development
    Phone icon
  • Stylized image of a person
    S. G.
    Senior Quality Assurance Specialist
    Phone icon
  • Stylized image of a person
    G. P.
    Senior Research Associate
    Phone icon

Ambys Medicines . Full-time Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Engineering
  • Finance
  • Operations
  • Quality Assurance
  • Other
  • Business Development
  • Accounting
  • Biotechnology
  • Business
  • Administrative

Contact profiles from Ambys Medicines . Full-time

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    D. N.
    Talent Discovery Partner, R&d
    Phone icon
    Oct 17, 2024
  • Stylized image of a person
    S. H.
    Vice President, Research And Nonclinical Development
    Phone icon
    Jul 12, 2023
  • Stylized image of a person
    S. G.
    Senior Quality Assurance Specialist
    Phone icon
    Bay
    Apr 14, 2026
  • Stylized image of a person
    G. P.
    Senior Research Associate
    Phone icon
    Oct 22, 2024

Frequently Asked Questions

What is Ambys Medicines . Full-time known for?

Minus sign iconPlus sign icon
Ambys Medicines . Full-time was founded in 2018 operates in the Biotechnology Research industry. Explore Ambys Medicines . Full-time's company overview page for more information.

What is Ambys Medicines . Full-time's most common email format?

Minus sign iconPlus sign icon
Ambys Medicines . Full-time employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Ambys Medicines . Full-time email formats with LeadIQ.

How many employees does Ambys Medicines . Full-time have currently?

Minus sign iconPlus sign icon
Ambys Medicines . Full-time has approximately 10 employees as of July 2026. These team members are located across 2 continents, including North AmericaAsia.

Who are Ambys Medicines . Full-time's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Ambys Medicines . Full-time's key employees include:

  • Talent Discovery Partner, R&d: D. N.
  • Vice President, Research And Nonclinical Development: S. H.
  • Senior Quality Assurance Specialist: S. G.
  • Senior Research Associate: G. P.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.